In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment, and ...
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30% ...
After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can ...
The expansion enables Previvor Edge clinicians to rapidly translate complex genetic, medical, family history, and lifestyle risk data into a comprehensive Cancer Risk Profile and ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient’s risk of hepatocellular carcinoma (HCC), the most common ...
Attachment to smart devices and biometric surveillance leaves Americans more vulnerable to police searches than ever. Left ...
India has launched its first repository of data on major psychiatric disorders, CALM-Brain, in Bengaluru. This initiative ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced a set of strategic efforts designed to accelerate earlier recognition and improve care coordination ...
Researchers have mapped 30 million cells to create a definitive atlas of the human neocortex. This blueprint reveals how human brain development differs from other mammals and provides a roadmap for ...
Watch a video spotlight with Dr. Colantuoni.In a bid to better understand, and potentially treat, a host of conditions that ...
Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...
Deep brain stimulation (DBS) has emerged as a standard of care in the treatment of Parkinson’s disease and other movement disorders, such as dystonia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results